What is the official website of Exact Sciences Precision Oncology ?

The official website of Exact Sciences Precision Oncology is https://precisiononcology.exactsciences.com/about-us.

What is Exact Sciences Precision Oncology's cybersecurity risk score?

Exact Sciences Precision Oncology has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Exact Sciences Precision Oncology experienced?

According to Rankiteo, Exact Sciences Precision Oncology currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Exact Sciences Precision Oncology been affected by any supply chain cyber incidents ?

According to Rankiteo, Exact Sciences Precision Oncology has been affected by a supply chain cyber incident involving Exact Sciences, with the incident ID ABBEXA1784305475.

Does Exact Sciences Precision Oncology have SOC 2 Type 1 certification ?

According to Rankiteo, Exact Sciences Precision Oncology is not certified under SOC 2 Type 1.

Does Exact Sciences Precision Oncology have SOC 2 Type 2 certification ?

According to Rankiteo, Exact Sciences Precision Oncology does not hold a SOC 2 Type 2 certification.

Does Exact Sciences Precision Oncology comply with GDPR ?

According to Rankiteo, Exact Sciences Precision Oncology is not listed as GDPR compliant.

Does Exact Sciences Precision Oncology have PCI DSS certification ?

According to Rankiteo, Exact Sciences Precision Oncology does not currently maintain PCI DSS compliance.

Does Exact Sciences Precision Oncology comply with HIPAA ?

According to Rankiteo, Exact Sciences Precision Oncology is not compliant with HIPAA regulations.

Does Exact Sciences Precision Oncology have ISO 27001 certification ?

According to Rankiteo,Exact Sciences Precision Oncology is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Exact Sciences Precision Oncology operate in ?

Exact Sciences Precision Oncology operates primarily in the Biotechnology Research industry.

How many employees does Exact Sciences Precision Oncology have ?

Exact Sciences Precision Oncology employs approximately None employees people worldwide.

Does Exact Sciences Precision Oncology own any subsidiaries ?

Exact Sciences Precision Oncology presently has no subsidiaries across any sectors.

How many LinkedIn followers does Exact Sciences Precision Oncology have ?

Exact Sciences Precision Oncology's official LinkedIn profile has approximately 7,870 followers.

What is the NAICS classification code for Exact Sciences Precision Oncology ?

Exact Sciences Precision Oncology is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Exact Sciences Precision Oncology have a Crunchbase profile ?

No, Exact Sciences Precision Oncology does not have a profile on Crunchbase.

Does Exact Sciences Precision Oncology have a LinkedIn profile ?

Yes, Exact Sciences Precision Oncology maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/exact-sciences-precision-oncology.

How many cybersecurity incidents has Exact Sciences Precision Oncology experienced ?

As of July 21, 2026, Rankiteo reports that Exact Sciences Precision Oncology has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Exact Sciences Precision Oncology have ?

Exact Sciences Precision Oncology has an estimated 4,730 peer or competitor companies worldwide.

What types of cybersecurity incidents has Exact Sciences Precision Oncology faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

ESPO

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Exact Sciences Precision Oncology Vendor Cyber Rating & Cyber Score

exactsciences.com

Add Your Compliance Badge

Delivering genomic testing across the stages of oncology care, with actionable insights to help inform personalized treatment decisions. Content reflects information available and is accurate at the time of publication.

ESPO A.I CyberSecurity Scoring

Scoring History

ESPO

Exact Sciences Precision Oncology CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Exact Sciences

Ransomware

100

7/2026

EXA1784199880

Exact Sciences

Cyber Attack

7/2026

Exact Sciences

ABBEXA178430547...

Loading…

A.I.

ESPO Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for ESPO

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Exact Sciences Precision Oncology in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Exact Sciences Precision Oncology in 2026.

Incident Types ESPO vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Exact Sciences Precision Oncology in 2026.

Incident History - ESPO (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Exact Sciences Precision Oncology Subsidiaries

ESPO

Biotechnology Research

Website: https://precisiononcology.exactsciences.com/about-us

Company Size: 201-500 employees

Exact SciencesBiotechnology Research

Genomic HealthBiotechnology Research

Cologuard® HCPBiotechnology Research

Loading…

Exact Sciences Precision Oncology Similar Companies

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Loading…

NEWS

Exact Sciences Precision Oncology CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 03, 2026 07:32 PM

Medicare opens door to multi-cancer blood tests that may catch tumors earlier

Passage of MCED legislation marks major milestone for early cancer detection. MADISON, Wis. --(BUSINESS WIRE)-- Exact Sciences Corp.

Read Article

February 03, 2026 02:03 PM

Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide

MADISON, Wis., February 03, 2026--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests,...

Read Article

December 11, 2025 08:00 AM

Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS

New data reveals Oncodetect's powerful prognostic performance in one of the largest TNBC MRD studies to date1. MADISON, Wis.

Read Article

December 03, 2025 08:00 AM

Why Is Exact Sciences (EXAS) Up 45.4% Since Last Earnings Report?

Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Read Article

November 24, 2025 11:58 AM

Abbott Signs $21 Bn Agreement to Acquire Exact Sciences, Accelerating Push Into Cancer Diagnostics

Abbott acquires Exact Sciences in a $21 billion agreement, strategically advancing its stance in the cancer diagnostics sector. The article elaborates on...

Read Article

November 24, 2025 08:00 AM

Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium

MADISON, Wis., November 24, 2025--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests,...

Read Article

November 23, 2025 08:00 AM

Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks

As the Q3 earnings season wraps, let's dig into this quarter's best and worst performers in the immuno-oncology industry, including Exact...

Read Article

November 21, 2025 08:00 AM

Abbott to acquire Exact Sciences in $21 billion deal, aiming to lead in fast-growing cancer diagnostics market

Deal is expected to accelerate innovation in cancer diagnostics and expand access to early detection tools at a time when global cancer...

Read Article

November 20, 2025 08:00 AM

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement for Abbott to acquire Exact Sciences,...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-15905

SUMMARY

Use after free in Aura in Google Chrome prior to 150.0.7871.128 allowed a local attacker to potentially exploit heap corruption via a malicious file. (Chromium security severity: High)

Published

Date2026-07-20

Updated

Date2026-07-20

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-15904

SUMMARY

Use after free in Ozone in Google Chrome on Linux prior to 150.0.7871.128 allowed a remote attacker who convinced a user to engage in specific UI gestures to potentially exploit heap corruption via a crafted HTML page. (Chromium security severity: High)

Published

Date2026-07-20

Updated

Date2026-07-20

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-15903

SUMMARY

Out of bounds read and write in V8 in Google Chrome prior to 150.0.7871.128 allowed a remote attacker to execute arbitrary code inside a sandbox via a crafted HTML page. (Chromium security severity: High)

Published

Date2026-07-20

Updated

Date2026-07-20

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-15902

SUMMARY

Use after free in Cast in Google Chrome prior to 150.0.7871.128 allowed a remote attacker to execute arbitrary code inside a sandbox via a crafted HTML page. (Chromium security severity: High)

Published

Date2026-07-20

Updated

Date2026-07-20

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-15901

SUMMARY

Use after free in Network in Google Chrome prior to 150.0.7871.128 allowed a remote attacker to potentially exploit heap corruption via a crafted HTML page. (Chromium security severity: Critical)

Published

Date2026-07-20

Updated

Date2026-07-20

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…